Comparing Analgesic Effects of Wound Infiltration Using Bupivacaine, Tramadol, and Tramadol Plus Bupivacaine

• Status: Not yet recruiting
• Trial end date: 2024-06-02
• Target enrollment: 0
• Participant gender: Female

Summary

The goal of this study's clinical trial is to compare in post-operative analgesic effectiveness of wound infiltration using bupivacaine, tramadol, and tramadol plus bupivacaine in patients undergoing elective cesarean section under spinal anesthesia. The main question the study aimed to answer is "which approach is best among the 3"

all participants need to respond to the pain severity for the data collectors and they will receive treatments accordingly There will be 3 groups in the study

• group T: for tramadol

• group B: for bupivacaine

• group TB : tramadol + bupivacaine

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Wollo University
• Treatments: Bupivacaine; Tramadol

Criteria

Inclusion Criteria:

• Women age between 18 and 35

• ASA risk class I-II

Exclusion Criteria:

• - Chronic pain diagnosis

• ASA above II

• Comorbidities (Anemia, DM, HTN, Arthritis)

• Known allergy to bupivacaine, tramadol

• History of alcohol, opiate, or other drug abuse

• Use of preoperative anti-pain